| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6494689 | Metabolic Engineering | 2013 | 9 Pages |
Abstract
The overall erythromycin biosynthetic pathway can be sub-divided into macrocyclic polyketide formation and polyketide tailoring to produce the final bioactive molecule. In this study, the native deoxysugar tailoring reactions were exchanged for the purpose of demonstrating the production of alternative final erythromycin compounds. Both the d-desosamine and l-mycarose deoxysugar pathways were replaced with the alternative d-mycaminose and d-olivose pathways to produce new erythromycin analogues through the Escherichia coli heterologous system. Both analogues exhibited bioactivity against multiple antibiotic-resistant Bacillus subtilis strains. Besides demonstrating an intrinsic flexibility for the biosynthetic system to accommodate alternative tailoring pathways, the results offer an initial attempt to leverage the E. coli platform for erythromycin analogue production.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Ming Jiang, Haoran Zhang, Sung-Hee Park, Yi Li, Blaine A. Pfeifer,